NEW YORK, Nov. 6 – Pyrosequencing and Genomics Collaborative said Tuesday that they had agreed to jointly collaborate to generate genomic information that could be used to develop diagnostics and therapeutic products for cardiovascular disease.

The deal is Pyrosequencing’s second such deal in the diagnostics market in as many days. On Monday, the Uppsala, Sweden-based company announced that it would work with the Cleveland Clinic to co-develop rapid identification and diagnostic tests for mycobacteria.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.